Metabolic aspects of the Beckwith-Wiedemann syndrome.
D000015:Abnormalities, Multiple / Q000188:drug therapy; D000307:Adrenal Gland Diseases / Q000188:drug therapy / Q000378:metabolism*; D001786:Blood Glucose / Q000032:analysis; D002675:Child, Preschool; D003981:Diazoxide / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005934:Glucagon; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006554:Hernia, Umbilical / Q000151:congenital; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006946:Hyperinsulinism / Q000378:metabolism; D007003:Hypoglycemia / Q000378:metabolism; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000378:metabolism*; D007328:Insulin / Q000097:blood; D007674:Kidney Diseases / Q000188:drug therapy / Q000378:metabolism*; D007930:Leucine; D008297:Male; D014044:Tolbutamide; D014059:Tongue / Q000002:abnormalities; D014472:Umbilicus / Q000002:abnormalities
D001786:Blood Glucose; D007328:Insulin; D013006:Growth Hormone; D005934:Glucagon; D014044:Tolbutamide; D007930:Leucine; D005947:Glucose; D003981:Diazoxide; D006854:Hydrocortisone; D004837:Epinephrine